(Q33388450)

26 July 2017

Patients with Epstein-Fechtner syndromes owing to MYH9 R702 mutations develop progressive proteinuric renal disease (English)

1 reference

26 July 2017

1 reference

Takashi Sekine

1

1 reference

26 July 2017

Mutsuko Konno

2

1 reference

26 July 2017

Satoshi Sasaki

3

1 reference

26 July 2017

Suzuko Moritani

4

1 reference

26 July 2017

Takuma Miura

5

1 reference

26 July 2017

Wai-shan Wong

6

1 reference

26 July 2017

Hisanori Nishio

7

1 reference

26 July 2017

Toshihiro Nishiguchi

8

1 reference

26 July 2017

Miyako Yoshinari Ohuchi

9

1 reference

26 July 2017

Shigeru Tsuchiya

10

1 reference

26 July 2017

Takeshi Matsuyama

11

1 reference

26 July 2017

Hirokazu Kanegane

12

1 reference

26 July 2017

Komei Ida

13

1 reference

26 July 2017

Kenichiro Miura

14

1 reference

26 July 2017

Yutaka Harita

15

1 reference

26 July 2017

Motoshi Hattori

16

1 reference

26 July 2017

Shigeru Horita

17

1 reference

26 July 2017

Takashi Igarashi

18

1 reference

26 July 2017

Hidehiko Saito

19

1 reference

26 July 2017

Shinji Kunishima

20

1 reference

26 July 2017

language of work or name

English

0 references

publication date

3 March 2010

1 reference

26 July 2017

1 reference

26 July 2017

78

1 reference

26 July 2017

207-214

1 reference

26 July 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.2010.21

26 July 2017

0 references

cites work

Historical hematology: May-Hegglin anomaly

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.21

7 January 2021

Mapping of a gene for May-Hegglin anomaly to chromosome 22q.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.21

7 January 2021

Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. The May-Heggllin/Fechtner Syndrome Consortium

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.21

7 January 2021

Mutation of MYH9, encoding non-muscle myosin heavy chain A, in May-Hegglin anomaly.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.21

7 January 2021

Mutations in the NMMHC-A gene cause autosomal dominant macrothrombocytopenia with leukocyte inclusions (May-Hegglin anomaly/Sebastian syndrome).

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.21

7 January 2021

Identification of six novel MYH9 mutations and genotype-phenotype relationships in autosomal dominant macrothrombocytopenia with leukocyte inclusions

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.21

7 January 2021

Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.21

7 January 2021

Genotype-phenotype correlation in MYH9-related thrombocytopenia

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.21

7 January 2021

Position of nonmuscle myosin heavy chain IIA (NMMHC-IIA) mutations predicts the natural history of MYH9-related disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.21

7 January 2021

https://api.crossref.org/works/10.1038%2FKI.2010.21

1 reference

7 January 2021

MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.21

7 January 2021

MYH9 is associated with nondiabetic end-stage renal disease in African Americans

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.21

7 January 2021

Hereditary macrothrombocytopathia, nephritis and deafness

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.21

7 January 2021

End-stage renal disease in two pediatric patients with Fechtner syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.21

7 January 2021

Genetics, clinical and pathological features of glomerulonephrites associated with mutations of nonmuscle myosin IIA (Fechtner syndrome)

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.21

7 January 2021

Immunofluorescence analysis of neutrophil nonmuscle myosin heavy chain-A in MYH9 disorders: association of subcellular localization with MYH9 mutations.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.21

7 January 2021

Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.21

7 January 2021

Mutational and Biological Analysis of alpha-actinin-4 in focal segmental glomerulosclerosis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.21

7 January 2021

FSGS-associated alpha-actinin-4 (K256E) impairs cytoskeletal dynamics in podocytes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.21

7 January 2021

Nonmuscle myosin II moves in new directions

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.21

7 January 2021

Renin-angiotensin system blockade is effective in reducing proteinuria of patients with progressive nephropathy caused by MYH9 mutations (Fechtner-Epstein syndrome).

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.21

7 January 2021

Haematological characteristics of MYH9 disorders due to MYH9 R702 mutations

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.21

7 January 2021

Identifiers

DOI

10.1038/KI.2010.21

1 reference

Dimensions Publication ID

26 July 2017

0 references

1 reference